Daily Papers / Chemical Biology Neuro-oncology ·1 Nov 2025 ·Added 12 Nov 2026 DDDR-26. Preclinical evaluation of first-in-class PROTAC survivin degrader HMAK101 for radiosensitization of CNS malignancies Authors not listed Chemical BiologyTargeted Protein Degradation Save Share Original ↗ No abstract is available from the indexing sources.